NZ260851A - 5-amino-1-cyclopropyl-8-methyl-4-oxo-7-pyrrolidinyl-quinoline -3-carboxylic acid derivatives and pharmaceutical compositions thereof - Google Patents

5-amino-1-cyclopropyl-8-methyl-4-oxo-7-pyrrolidinyl-quinoline -3-carboxylic acid derivatives and pharmaceutical compositions thereof

Info

Publication number
NZ260851A
NZ260851A NZ260851A NZ26085194A NZ260851A NZ 260851 A NZ260851 A NZ 260851A NZ 260851 A NZ260851 A NZ 260851A NZ 26085194 A NZ26085194 A NZ 26085194A NZ 260851 A NZ260851 A NZ 260851A
Authority
NZ
New Zealand
Prior art keywords
methyl
compound
carboxylic acid
stereoisomer
acceptable salt
Prior art date
Application number
NZ260851A
Other languages
English (en)
Inventor
Yasuo Ito
Hideo Kato
Singo Yasuda
Noriyuki Kado
Toshihiko Yoshida
Yoichi Yamamoto
Original Assignee
Hokuriku Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical filed Critical Hokuriku Pharmaceutical
Publication of NZ260851A publication Critical patent/NZ260851A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Epoxy Resins (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
NZ260851A 1993-08-27 1994-06-24 5-amino-1-cyclopropyl-8-methyl-4-oxo-7-pyrrolidinyl-quinoline -3-carboxylic acid derivatives and pharmaceutical compositions thereof NZ260851A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23431093 1993-08-27
JP28627293 1993-10-22
JP7631894 1994-03-24

Publications (1)

Publication Number Publication Date
NZ260851A true NZ260851A (en) 1996-03-26

Family

ID=27302121

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ260851A NZ260851A (en) 1993-08-27 1994-06-24 5-amino-1-cyclopropyl-8-methyl-4-oxo-7-pyrrolidinyl-quinoline -3-carboxylic acid derivatives and pharmaceutical compositions thereof

Country Status (23)

Country Link
US (1) US5547962A (OSRAM)
EP (1) EP0641793B1 (OSRAM)
JP (1) JP2673937B2 (OSRAM)
KR (1) KR100218807B1 (OSRAM)
CN (1) CN1048242C (OSRAM)
AT (1) ATE144508T1 (OSRAM)
AU (1) AU676729B2 (OSRAM)
CA (1) CA2126118C (OSRAM)
CZ (1) CZ286524B6 (OSRAM)
DE (1) DE69400791T2 (OSRAM)
DK (1) DK0641793T3 (OSRAM)
ES (1) ES2096413T3 (OSRAM)
FI (1) FI113174B (OSRAM)
GR (1) GR3021715T3 (OSRAM)
HU (1) HU221952B1 (OSRAM)
IL (1) IL110060A (OSRAM)
MY (1) MY111702A (OSRAM)
NO (1) NO305515B1 (OSRAM)
NZ (1) NZ260851A (OSRAM)
PL (1) PL175870B1 (OSRAM)
SG (1) SG52147A1 (OSRAM)
TW (1) TW252107B (OSRAM)
UA (1) UA39859C2 (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980701625A (ko) * 1995-01-24 1998-06-25 이토 마사노리 퀴놀린카르본산유도체
US6121285A (en) * 1995-11-22 2000-09-19 Daiichi Pharmaceutical Co., Ltd. Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted aminocycloalkylpyrrolidine derivatives
MY138335A (en) * 1997-09-15 2009-05-29 Procter & Gamble Antimicrobial quinolones, their compositions and uses
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
EP1132375B1 (en) 1998-11-18 2003-07-16 Asahi Glass Company Ltd. Aminoacrylic acid derivatives and process for producing the same
CA2367373C (en) 1999-03-17 2011-09-20 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
IL151035A0 (en) * 2000-02-09 2003-04-10 Daiichi Seiyaku Co Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
US6825353B2 (en) 2000-02-25 2004-11-30 Daiichi Pharmaceutical Co., Ltd. Process for producing quinolonecarboxylic acids and intermediates thereof
EP1258478A4 (en) * 2000-02-25 2006-03-15 Daiichi Seiyaku Co PROCESS FOR THE PREPARATION OF CHINOLONCARBOXYLIC ACIDS AND THEIR INTERMEDIATE PRODUCTS
KR20010044286A (ko) * 2001-02-01 2001-06-05 남근수 알킬-3-(2,6-디할로겐-5-플루오로)-옥소-3-피리딘프로피오네이트의 제조방법
JP5017101B2 (ja) * 2005-05-20 2012-09-05 第一三共株式会社 不斉四置換炭素原子含有化合物の製法
US7842818B2 (en) 2005-09-28 2010-11-30 Daiichi Sankyo Company, Limited Process for preparation of tetrasubstituted 5-azaspiro[2.4]- heptane derivatives and optically active intermediates thereof
CA2647454A1 (en) * 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
DK2001862T3 (da) * 2006-03-28 2011-08-08 Warner Chilcott Co Llc Malatsalte og polymorfe af (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyklopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolincarboxylsyre
US7528264B2 (en) * 2006-03-28 2009-05-05 The Procter & Gamble Company Hydride reduction process for preparing quinolone intermediates
TWI362386B (en) * 2007-03-30 2012-04-21 Daiichi Sankyo Co Ltd A production method for the qunolon-carboxylic acid derivative
FR2928150A1 (fr) * 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
JPH0635457B2 (ja) * 1985-06-28 1994-05-11 杏林製薬株式会社 ピリドンカルボン酸誘導体およびその製造方法
DE3608745A1 (de) * 1985-07-24 1987-01-29 Bayer Ag Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin
JPH0637489B2 (ja) * 1985-09-21 1994-05-18 杏林製薬株式会社 キノロンカルボン酸誘導体およびその製造方法
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
JPS62215572A (ja) 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
EP0251308B1 (de) * 1986-07-04 1990-11-22 Chemie Linz Gesellschaft m.b.H. 4-Chinolon-3-carbonsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
US4771055A (en) * 1986-07-28 1988-09-13 Warner-Lambert Company 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids
JPS63152318A (ja) * 1986-08-07 1988-06-24 Dainippon Pharmaceut Co Ltd 抗マイコプラズマ剤
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
US5190955A (en) * 1987-01-28 1993-03-02 Bayer Aktiengesellschaft Antibacterial 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
JPS63275567A (ja) * 1987-05-07 1988-11-14 Dainippon Pharmaceut Co Ltd 新規キノリン誘導体、そのエステルおよびその塩
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
US5164392A (en) * 1987-10-16 1992-11-17 Dainippon Pharmaceutical Co., Ltd. Quinoline derivatives and antibacterial agent containing them
US5173484A (en) * 1988-02-05 1992-12-22 Bayer Aktiengesellschaft Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
JPH0219377A (ja) * 1988-07-08 1990-01-23 Kyorin Pharmaceut Co Ltd ８‐メチルキノロンカルボン酸誘導体
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5286723A (en) * 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
IE76284B1 (en) * 1988-09-22 1997-10-08 Abbott Lab Amino acid quinoline and naphthyridine derivatives
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
CA2012063A1 (en) * 1989-03-15 1990-09-15 Hirosato Kondo Quinolinecarboxylic acid derivatives and antibacterial agent containing the same
DE69019859T2 (de) * 1989-03-30 1995-10-05 Wakunaga Seiyaku Kk Chinolon-Derivate und deren Salze, Verfahren zu deren Herstellung und diese enthaltende antibakterielle Wirkstoffe.
CA2012681A1 (en) * 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
DE3910920A1 (de) * 1989-04-05 1990-10-11 Bayer Ag Enantiomerenreine 7-(3-amino-1-pyrrolidinyl)-chinolon- und -naphthyridoncarbonsaeuren
DE4032560A1 (de) * 1990-10-13 1992-04-16 Bayer Ag 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate
HU9301648D0 (en) * 1990-12-05 1993-09-28 Synphar Lab Inc Substituted oxaquinoline-3-carboxylic acids of bactericidal effect and method for producing them
US5137892A (en) * 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
KR950014567B1 (ko) * 1991-08-01 1995-12-08 주식회사대웅제약 신규한 퀴놀론 카르복실산 유도체

Also Published As

Publication number Publication date
CN1048242C (zh) 2000-01-12
FI942976A7 (fi) 1995-02-28
FI942976A0 (fi) 1994-06-21
DE69400791T2 (de) 1997-03-06
KR950005823A (ko) 1995-03-20
CA2126118A1 (en) 1995-02-28
NO305515B1 (no) 1999-06-14
FI113174B (fi) 2004-03-15
EP0641793B1 (en) 1996-10-23
KR100218807B1 (ko) 1999-09-01
ES2096413T3 (es) 1997-03-01
CZ286524B6 (cs) 2000-05-17
JPH07309864A (ja) 1995-11-28
UA39859C2 (uk) 2001-07-16
US5547962A (en) 1996-08-20
DE69400791D1 (de) 1996-11-28
DK0641793T3 (da) 1996-11-25
HU9401954D0 (en) 1994-09-28
NO942309L (no) 1995-02-28
PL175870B1 (pl) 1999-02-26
IL110060A0 (en) 1994-10-07
ATE144508T1 (de) 1996-11-15
HUT67259A (en) 1995-03-28
AU676729B2 (en) 1997-03-20
EP0641793A1 (en) 1995-03-08
CN1117491A (zh) 1996-02-28
CZ157494A3 (en) 1995-10-18
MY111702A (en) 2000-11-30
JP2673937B2 (ja) 1997-11-05
CA2126118C (en) 2001-02-06
HU221952B1 (hu) 2003-03-28
GR3021715T3 (en) 1997-02-28
SG52147A1 (en) 1998-09-28
TW252107B (OSRAM) 1995-07-21
AU6487094A (en) 1995-03-09
NO942309D0 (no) 1994-06-17
IL110060A (en) 1999-10-28
PL304063A1 (en) 1995-03-06

Similar Documents

Publication Publication Date Title
Chu et al. Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents
NZ260851A (en) 5-amino-1-cyclopropyl-8-methyl-4-oxo-7-pyrrolidinyl-quinoline -3-carboxylic acid derivatives and pharmaceutical compositions thereof
CA1340402C (en) Quinoline derivatives and processes for preparation thereof
SK286420B6 (sk) Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie
HU199821B (en) Process for production of derivatives of in 8 position substituated quinoline carbonic acid and medical compositions containing them
MXPA05001180A (es) Derivados aza-biciclicos antimicrobianos, sus composiciones y usos.
JP2004515548A (ja) 抗微生物キノロン
NZ221021A (en) 7-((3-(aminomethyl)-3-alkyl)-1-pyrrolidinyl)-quinoline and naphthyridine derivatives and pharmaceutical compositions containing such
EP0314362A2 (en) Azetidinyl quinolone carboxylic acids and esters
JPH07138256A (ja) キノリン誘導体
EP0306860A2 (en) 4-Oxo-3-Quinolinecarboxylic acids useful as antibacterial agents and preparation thereof
RU2130932C1 (ru) Производные 5-амино-8-метил-7-пирролидинилхинолин-3-карбоновой кислоты, способы их получения, фармацевтическая композиция, способ лечения, промежуточный продукт
US4720495A (en) Benzo[ij]quinolizine-2-carboxylic acids useful for treating bacterial infection
JP2001506242A (ja) ヘリコバクター・ピロリ感染及びそれらと関連する胃十二指腸疾患を処置するための７−（１−アミノメチル−２−オキサ−７−アザ−ビシクロ［３．３．０］オクト−７−イル）−キノロンカルボン酸及びナフチリドンカルボン酸誘導体の使用
JPH06199835A (ja) ８−ジフルオロメトキシキノリン−３−カルボン酸誘導体
FI70219B (fi) Foerfarande foer framstaellning av en beta-laktamantibiotikumfoerening
US5126337A (en) Thiazetoquinoline-3-carboxylic acid derivative and a pharmaceutical composition comprising the same
KR100245982B1 (ko) 신규한 퀴놀론카르복실산 유도체
JPH05345777A (ja) ７−（４，４−ジアルキル−３−アミノ置換ピロリジニル）キノロン−３−カルボン酸誘導体
JP2621292B2 (ja) 抗菌化合物
KR970001159B1 (ko) 신규 1,8-나프티리딘 유도체 및 그의 제조방법
EP0486687A1 (en) Quinolonecarboxylic acid derivatives
CN112239457B (zh) 一种乙酰基连接的加替沙星-1,2,3-三氮唑-靛红杂合体及其制备方法和应用
JPH06145167A (ja) ８−メトキシ−５−メチルキノリン−３−カルボン酸誘導体
JPH05247059A (ja) チアゼトキノリン−３−カルボン酸誘導体

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired